Researchers have found a molecule that is effective against tuberculosis, says a new study on mice.
In the study, the group describes how it worked when tested in vitro and in a mouse model.
Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis (Mtb). This airborne pathogen tends to infect the lungs and is passed from person to person.
Back in the 1950s, researchers developed drugs to treat the disease. However, since that time, the bacteria has become resistance today, and almost one-third of all new cases are caused by antimicrobial-resistant strains.
In this new effort, published in the journal Science, the researchers from University of Cape Town in South Africa, found that introducing the 8918 molecule to Mtb in a petri dish resulted in its death.
In addition, they also found that administering the molecule to Mtb mouse models killed some of the bacteria they carried without harming them.
However, before 8918 can be considered a candidate for clinical trials, researchers must overcome one obstacle -- it has a short half-life, which results in rapid microsomal metabolism indicating that it does not hang around long enough to kill many Mtb before the body flushes it away, the study noted.
--IANS
pb/ksk
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
